Celgene backs out of a $55m deal to settle claims of thwarting generics

Celgene backs out of a $55m deal to settle claims of thwarting generics

STAT Plus: They did what? Celgene backs out of a $55 million deal to settle claims of thwarting generics

By ED SILVERMAN

KRISTOFFER TRIPPLAAR/SIPA VIA AP

“It’s extremely rare and I can’t think of another situation where that happened,” said Carl Tobias, a professor at the University of Richmond law school.

READ MORE